| Name | Title | Contact Details |
|---|---|---|
John Minardo |
Senior Vice President and Chief Legal Officer | Profile |
Diane Stroehmann |
Vice President Regulatory Affairs and Global Patient Safety | Profile |
Conor Kilroy |
Senior Vice President, General Counsel | Profile |
Karen Brown |
Vice President and Chief Intellectual Property Counsel | Profile |
Vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world`s most challenging infectious diseases for which solutions are non-existent or inadequate. Vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. The company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Alltrna is the first transfer RNA (tRNA) platform company, and our mission is to unlock tRNA biology and pioneer tRNA therapeutics to regulate the protein universe and resolve disease. Founded at Flagship Labs in 2018, Alltrna has mapped tRNA biology to systematically design tRNA medicines and encode a completely new, unifying approach to treating both rare and common human diseases driven by shared genetic mutations. Alltrna`s platform combines internal expertise and proprietary machine learning tools to unlock the entire tRNA biology space. We have an unprecedented opportunity to advance a single tRNA medicine to restore disrupted protein production, regardless of target, for thousands of diseases with the same underlying genetic mutation.
Spaltudaq Corporation is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
CepTor Corporation is a Cockeysville, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.